| # | Drug | Count |
|---|---|---|
| 0 | RALTEGRAVIR | 31 |
| 1 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 27 |
| 2 | RITONAVIR | 27 |
| 3 | DARUNAVIR | 26 |
| 4 | ETRAVIRINE | 25 |
| 5 | ZIDOVUDINE | 25 |
| 6 | VALPROATE SODIUM | 17 |
| 7 | FOLIC ACID | 16 |
| 8 | LAMOTRIGINE | 13 |
| 9 | PREDNISOLONE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RALTEGRAVIR | 31 | 0.0059 |
| 1 | ETRAVIRINE | 25 | 0.0056 |
| 2 | NITROUS OXIDE | 11 | 0.0050 |
| 3 | ZIDOVUDINE | 25 | 0.0024 |
| 4 | BUPRENORPHINE HCL | 2 | 0.0023 |
| 5 | DARUNAVIR | 26 | 0.0017 |
| 6 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 6 | 0.0017 |
| 7 | PORACTANT ALFA | 1 | 0.0014 |
| 8 | DIFLUNISAL | 1 | 0.0012 |
| 9 | DARUNAVIR 600 MG | 6 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 26 | 0.0011 |
| 1 | Surfactant [EPC] | 1 | 0.0009 |
| 2 | Protease Inhibitor [EPC] | 30 | 0.0007 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 30 | 0.0005 |
| 4 | Vitamin K [EPC] | 3 | 0.0003 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 37 | 0.0003 |
| 6 | Progesterone [EPC] | 6 | 0.0003 |
| 7 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 8 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0002 |